List of Sodium Thiosulfate drug patents
Sodium Thiosulfate is owned by Hope Pharms.
Sodium Thiosulfate contains Sodium Thiosulfate.
Sodium Thiosulfate has a total of 4 drug patents out of which 0 drug patents have expired.
Sodium Thiosulfate was authorised for market use on 14 February, 2012.
Sodium Thiosulfate is available in solution;intravenous dosage forms.
Sodium Thiosulfate can be used as treatment of acute cyanide poisoning that is judged to be life threatening, sodium thiosulfate injection is administered by intravenous injection, sodium thiosulfate injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning.
The generics of Sodium Thiosulfate are possible to be released after 29 March, 2031.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9585912 | HOPE PHARMS | Sodium thiosulfate-containing pharmaceutical compositions |
Jul, 2030
(7 years from now) | |
| US9345724 | HOPE PHARMS | Sodium thiosulfate-containing pharmaceutical compositions |
Jul, 2030
(7 years from now) | |
| US8496973 | HOPE PHARMS | Sodium thiosulfate-containing pharmaceutical compositions |
Mar, 2031
(8 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10479686 | HOPE PHARMS | Sodium thiosulfate-containing pharmaceutical compositions |
Jul, 2030
(7 years from now) | |
Drugs and Companies using SODIUM THIOSULFATE ingredient
Market Authorisation Date: 14 February, 2012
Treatment: Sodium thiosulfate injection is administered by intravenous injection; Sodium thiosulfate injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning; Treatment of acute cyanide poisoning that is judged to be life threatening
Dosage: SOLUTION;INTRAVENOUS
SODIUM THIOSULFATE family patents
14
United States
7
Japan
2
European Union
1
Portugal
1
Hungary
1
Poland
1
Australia
1
Norway
1
Denmark
1
Spain
1
Canada
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic